Join our strategy for SARS-CoV2 virus detection
DIOS RT-qPCR Screening Kit and DIOS RT-qPCR POCT Kit
Join our strategy for SARS-CoV2 virus detection
DIOS RT-qPCR Screening Kit and DIOS RT-qPCR POCT Kit
5. 1. 2023
IAB invites all those interested in Optical Genome Mapping (OGM) to the traditional Bionano Symposium online conference on
2. 6. 2022
We invite all scientists and clinicians attending ESHG 2022 in Vienna to a pre-conference evening organized by the
27. 1. 2022
Press release, 27.1.2021 Cambridge, United Kingdom and Prague, Czech Republic – 27.1.2021 - Congenica, the digital health company enabling
24. 1. 2022
Press release, 25.1.2022 Purigen Biosystems Announces Commercial Distribution Agreement with the Institute of Applied Biotechnologies for Automated Ionic® Purification
9. 9. 2020
Institute of Applied Biotechnology a.s. is introducing a CE IVD certified SARS-CoV-2 diagnostic test developed in cooperation with
7. 9. 2020
Czech digital genomics service provider Institute of Applied Biotechnologies (IAB) has partnered with the Second Faculty of Medicine
27. 8. 2020
The IAB company is a member of "WHO European Region sequencing laboratories and GISAID EpiCoV group"a co-author of the
8. 6. 2020
IAB Poster ESHG Conference 2020 The IAB company developed a robust WGS protocol including all essential QC steps, library
17. 5. 2020
Firma Institute of Applied Biotechnologies a.s. (IAB) ve spolupráci s odborníky 2. LF Univerzity Karlovy v Praze iniciuje
6. 3. 2020
WGS and WES validation – challenges Author: Martin Kašný (Institute of Applied Biotechnologies a.s.) Co-authors: Kvapilová Kateřina (IAB a.s., PřF UK),
High-quality NGS sequencing of SARS-Cov 2 virus generating data for de novo assembly.
We provide sequencing services to public and private healthcare and as well as for research partners. NGS services from one sample to the whole project.
The IAB TSO 500 represents a powerful assay enabling the genomic profiling of DNA (523 genes) and RNA (55 genes) variants implicated in various tumor types.
The IAB Exome represents a cost-effective alternative to whole-genome sequencing. IAB Exom targets clinically relevant exome regions.
The IAB RNA-seq product can be used for precise detection of differentially expressed genes (DEG) from bacteria to mammals with strand specificity.
IAB genome is prepared with PCR free workflow to ensure the minimum bias presentence due to eliminating PCR step.
We have sent our samples for RNA-seq analysis to several international facilities and what we especially appreciate about IAB is the feedback and interaction on daily basis as well as excellent sequencing services.
Institute of Microbiology of the Czech Academy of Sciences, Laboratory of post-transcriptional control of gene expression
Members of our lab very appreciate a positive approach regarding the sequencing services. It is not dependent on which kind of library we need to sequence, always fast and well done work.
Mendeleum - Institute of Genetics and Plant Breeding
We used Illumina High Seq service for genome re-sequencing of green algae to identify mutation locations. The service was fast and reliable.
Institute of Microbiology of the CAS, v.v.i., Laboratory of Cell Cycles of Algae
Institute of Applied Biotechnologies, a.s.
Služeb 3056/4, 108 00 Praha-Strašnice
E-mail: iabio@iabio.eu
Phone: +420 255 700 885